Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Int J Med Mushrooms ; 17(9): 819-28, 2015.
Article in English | MEDLINE | ID: mdl-26756294

ABSTRACT

An Escherichia coli-expressed peptide with a molecular weight of 28.26, derived from the complementary DNA of antiviral protein RC28 isolated from the mushroom Rozites caperata (=Cortinarius caperatus), demonstrated potent antiviral activity against herpes simplex virus-1 in Vero cells and in a herpes simplex virus-1 mouse keratitis model. Plaque assays in Vero cells showed that the peptide reduced viral yields by at least 1.2 logs; in the animal model the cloned peptide delayed the occurrence of stromal keratitis and alleviated the severity of the disease. We believe this is the first report of a cloned mushroom peptide with antiviral activity for the prevention and treatment of a viral disease.


Subject(s)
Antiviral Agents/therapeutic use , Basidiomycota/chemistry , Corneal Diseases/virology , Corneal Stroma/drug effects , Herpesvirus 1, Human/drug effects , Keratitis, Herpetic/drug therapy , Peptides/therapeutic use , Agaricales , Animals , Antiviral Agents/isolation & purification , Antiviral Agents/pharmacology , Chlorocebus aethiops , Cloning, Molecular , Corneal Stroma/virology , DNA, Complementary , Disease Models, Animal , Escherichia coli , Female , Herpesvirus 1, Human/growth & development , Keratitis, Herpetic/virology , Mice, Inbred BALB C , Peptides/isolation & purification , Peptides/pharmacology , Severity of Illness Index , Vero Cells
SELECTION OF CITATIONS
SEARCH DETAIL